Cargando…
Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
Background and aims: Brazilian patients with inflammatory bowel diseases (IBD) requiring therapy with biological agents usually have access to medicines through the National Unified Health Care System (SUS). This study aimed to analyze Brazilian IBD patient perception regarding access (availability...
Autores principales: | Parra, Rogerio Serafim, da Costa Ferreira, Sandro, Machado, Vanessa Foresto, Nigro, Cintia Maura Caseiro, da Rocha, José Joaquim Ribeiro, de Almeida Troncon, Luiz Ernesto, Feres, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095198/ https://www.ncbi.nlm.nih.gov/pubmed/37048755 http://dx.doi.org/10.3390/jcm12072672 |
Ejemplares similares
-
COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil
por: Feitosa, Marley Ribeiro, et al.
Publicado: (2021) -
Spontaneous transvaginal small bowel evisceration: a case report
por: Parra, Rogério Serafim, et al.
Publicado: (2010) -
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
por: Parra, Rogerio Serafim, et al.
Publicado: (2015) -
PPARG expression in colorectal cancer and its association with staging and clinical evolution
(1)
por: Villa, Andre Luiz Prezotto, et al.
Publicado: (2020) -
Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study
por: Parra, Rogério Serafim, et al.
Publicado: (2023)